Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
369
datasets available to search
ShareScore release 0.9.0
Dataset results
369 results for “adalimumab”
Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT00338754. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Therapeutic Drug Monitoring of Adalimumab in Psoriasis Patients
ClinicalTrials.gov study NCT02147600. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Effect of Adalimumab (Humira) on Vascular Abnormalities in Rheumatoid Arthritis. A Pilot Study.
ClinicalTrials.gov study NCT01270087. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Quality of Life and Psychosocial Factors Associated With Severe Psoriasis Following Treatment With Adalimumab
ClinicalTrials.gov study NCT01328366. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Bone Resorption, Osteoclastogenesis and Adalimumab
ClinicalTrials.gov study NCT00814866. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Switching From Adalimumab to Infliximab
ClinicalTrials.gov study NCT01338740. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07))
ClinicalTrials.gov study NCT02237729. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
ClinicalTrials.gov study NCT05051943. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Therapeutic Monitoring of Infliximab and Adalimumab
ClinicalTrials.gov study NCT06033469. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Evaluation of the Efficacy, Safety and Immunogenicity of Adalimumab in Comparison With Humira®
ClinicalTrials.gov study NCT06005532. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Observational Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Pediatric Participants With Polyarticular Juvenile Idiopathic Arthritis (pJIA)
ClinicalTrials.gov study NCT05411211. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Progress at Work - The Impact of Adalimumab on Work Related Productivity in Patients With Rheumatoid Arthritis
ClinicalTrials.gov study NCT02362074. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
An Observational Study of Fecal Calprotectin as Clinical Tool in Monitoring Moderate-to-severe Crohn's Disease on Adalimumab Induction Therapy: a KoRean Experience (FAIR)
ClinicalTrials.gov study NCT01759264. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Study of Adalimumab (HUMIRA®) in Patients With Moderate to Severe Psoriasis (PS) in Spain (PROMISE)
ClinicalTrials.gov study NCT01076192. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Changes in Ultrasonographic Assessment of Inflammation Upon Initiation of Adalimumab Combination Therapy in Chinese Rheumatoid Arthritis (RA) Patients With Inadequate Response to Methotrexate
ClinicalTrials.gov study NCT02786563. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study to Assess Safety and Effectiveness of Adalimumab for Treating Children and Adolescents With Crohn's Disease in Real Life Conditions
ClinicalTrials.gov study NCT03017014. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Apremilast and Adalimumab in Psoriatic Arthritis Patients
ClinicalTrials.gov study NCT07398651. IPD Sharing: YES. Countries: 1. Publications: 0.
Impact of Adalimumab (Humira®) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis in Clinical Practice
ClinicalTrials.gov study NCT01754727. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis
ClinicalTrials.gov study NCT00233558. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fluorescence Imaging of Adalimumab-680LT and Risankizumab-800CW in Inflammatory Bowel Disease
ClinicalTrials.gov study NCT07258641. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.